StockNews.com Downgrades ICU Medical (NASDAQ:ICUI) to Hold

ICU Medical (NASDAQ:ICUI) was downgraded by equities researchers at StockNews.com from a “buy” rating to a “hold” rating in a research report issued on Thursday.

Several other equities research analysts have also recently issued reports on the stock. Raymond James set a $97.00 target price on shares of ICU Medical in a research report on Wednesday, March 12th. Jefferies Financial Group upgraded shares of ICU Medical from a “hold” rating to a “buy” rating and set a $200.00 price target on the stock in a report on Wednesday, December 11th. Two investment analysts have rated the stock with a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $168.67.

ICU Medical Stock Performance

Shares of ICUI stock opened at $140.16 on Thursday. The stock has a fifty day moving average price of $154.42 and a 200 day moving average price of $163.84. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29. The stock has a market cap of $3.44 billion, a PE ratio of -30.67 and a beta of 0.73. ICU Medical has a 1 year low of $93.36 and a 1 year high of $196.26.

Insiders Place Their Bets

In related news, CEO Vivek Jain sold 1,373 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total transaction of $213,474.04. Following the transaction, the chief executive officer now owns 104,593 shares in the company, valued at $16,262,119.64. This trade represents a 1.30 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 6.70% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On ICU Medical

Several large investors have recently made changes to their positions in the business. Vanguard Group Inc. boosted its stake in shares of ICU Medical by 0.7% during the 4th quarter. Vanguard Group Inc. now owns 2,682,065 shares of the medical instruments supplier’s stock worth $416,176,000 after acquiring an additional 17,805 shares in the last quarter. State Street Corp grew its position in ICU Medical by 9.3% during the 3rd quarter. State Street Corp now owns 907,607 shares of the medical instruments supplier’s stock worth $165,384,000 after purchasing an additional 77,506 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in shares of ICU Medical by 7.4% in the fourth quarter. JPMorgan Chase & Co. now owns 708,382 shares of the medical instruments supplier’s stock valued at $109,920,000 after purchasing an additional 49,108 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of ICU Medical by 9.6% in the third quarter. Geode Capital Management LLC now owns 546,954 shares of the medical instruments supplier’s stock worth $99,687,000 after buying an additional 48,106 shares during the period. Finally, Dimensional Fund Advisors LP raised its position in ICU Medical by 18.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 539,981 shares of the medical instruments supplier’s stock valued at $83,788,000 after buying an additional 82,982 shares during the period. Institutional investors own 96.10% of the company’s stock.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.